Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-12-01T02:26:42.575Z Has data issue: false hasContentIssue false
  • English
  • Français

Antibiotic Awareness Week and Hospital Antimicrobial Use Point Prevalence Study

Published online by Cambridge University Press:  16 November 2017

Nalini Singh ,
Arno Muller ,
Gabriel Levy Hara ,
Jose Luis Castro  and
Pilar Ramon-Pardo
Nalini Singh*
Affiliation:
Department of Pediatrics, George Washington University, Washington, DC
Arno Muller
Affiliation:
World Health Organization, Geneva, Switzerland
Gabriel Levy Hara
Affiliation:
Department of Clinical Microbiology and Infectious Diseases, School of Medicine, Buenos Aires, Argentina
Jose Luis Castro
Affiliation:
Pan American Health Organization, Washington DC
Pilar Ramon-Pardo
Affiliation:
Pan American Health Organization, Washington DC
*
Address correspondence to Nalini Singh, Department of Pediatrics, George Washington University, Children’s National Health System, 111 Michigan Ave, NW, Washington, DC, 20010 ([email protected]).
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Commentaries
Information
Infection Control & Hospital Epidemiology , Volume 38 , Issue 12 , December 2017 , pp. 1498 - 1500
Copyright
© 2017 by The Society for Healthcare Epidemiology of America. All rights reserved 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. Antimicrobial resistance. Organization for Economic Co-operation and Development website. http://www.oecd.org/els/health-systems/antimicrobial-resistance.htm. Published 2017. Accessed September 7, 2017.Google Scholar
2. G20 health ministers’ meeting: fighting antimicrobial resistance. Organization for Economic Co-operation and Development website. http://www.oecd.org/about/secretary-general/g20-health-ministers-meeting-fighting-antimicrobial-resistance.htm. Published 2017. Accessed September 7, 2017.Google Scholar
3. WHO publishes list of bacteria for which new antibiotics are urgently needed. World Health Organization website. http://www.who.int/mediacentre/news/releases/2017/bacteria-antibiotics-needed/en/. Published 2017. Accessed September 7, 2017.Google Scholar
4. Srinivasan, A, Stundick, M, Sun, E, Theuretzbacher, U, Wallace, B, Wise, B. Value-based strategies for encouraging new development of antimicrobial drugs. Duke Margolis Center for Health Policy website. https://healthpolicy.duke.edu/sites/default/files/atoms/files/value-based_strategies_for_encouraging_new_development_of_antimicrobial_drugs.pdf. Published 2017. Accessed September 7, 2017.Google Scholar
5. Global Point Prevalence Survey on Antimicrobial Consumption and Resistance. Global-PPS website. http://www.global-pps.com/. Update 2017. Accessed November 6, 2017.Google Scholar
6. Baur, D, Gladstone, B, Burkert, F, et al. Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis. Lancet Infect Dis 2017;17:990–1001.CrossRefGoogle ScholarPubMed
7. Low and middle-income data. World Bank website. http://data.worldbank.org/income-level/low-and-middle-income. Published 2017. Accessed September 7, 2017.Google Scholar
8. Human Development Report, pp. 198–201. United Nations Development Program website. http://hdr.undp.org/en/2016-report. Published 2016. Accessed September 7, 2017.Google Scholar
9. Antimicrobial resistance. Pan American Health Organization website. http://www.paho.org/hq/index.php?option=com_topics&view=article&id=7&Itemid=40740. Updated 2017. Accessed September 11, 2017.Google Scholar
10. WHO Guidelines for Carbapenem-resistant Enterobacteriaceae and Carbapenemase-producing Pseudomonas aeruginosa and Acinetobacter baumannii in Health Care (update forthcoming in November 2017).Google Scholar
11. Facility guidance for control of carbapenem-resistant Enterobacteriaceae (CRE)—November 2015 Update: CRE Toolkit. Centers for Disease Control and Prevention website. https://www.cdc.gov/hai/organisms/cre/cre-toolkit/index.html. Published 2017. Accessed September 7, 2017.Google Scholar
12. CARB-X partners. Public Health Emergency website. https://www.phe.gov/about/barda/CARB-X/Pages/partners.aspx. Published 2017. Accessed September 7, 2017.Google Scholar